Search Results - "Diogenes, Maria Jose"
-
1
Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair ltp via NMDA-receptor activation
Published in The Journal of neuroscience (22-08-2012)“…Copyright © 2012 the authors Parkinson's disease (PD) is the most common representative of a group of disorders known as synucleinopathies, in which misfolding…”
Get full text
Journal Article -
2
Spatiotemporal Dysregulation of Neuron-Glia Related Genes and Pro-/Anti-Inflammatory miRNAs in the 5xFAD Mouse Model of Alzheimer's Disease
Published in International journal of molecular sciences (31-08-2024)“…Alzheimer's disease (AD), the leading cause of dementia, is a multifactorial disease influenced by aging, genetics, and environmental factors. miRNAs are…”
Get full text
Journal Article -
3
Chocolate Consumption is Associated with a Lower Risk of Cognitive Decline
Published in Journal of Alzheimer's disease (22-06-2016)“…Cocoa-related products like chocolate have taken an important place in our food habits and culture. In this work, we aim to examine the relationship between…”
Get more information
Journal Article -
4
Impairment of adenosinergic system in Rett syndrome: Novel therapeutic target to boost BDNF signalling
Published in Neurobiology of disease (01-11-2020)“…Rett syndrome (RTT; OMIM#312750) is mainly caused by mutations in the X-linked MECP2 gene (methyl-CpG-binding protein 2 gene; OMIM*300005), which leads to…”
Get full text
Journal Article -
5
Dysregulation of TrkB receptors and BDNF function by amyloid-β peptide is mediated by calpain
Published in Cerebral cortex (New York, N.Y. 1991) (01-09-2015)“…© The Author 2014. Published by Oxford University Press. All rights reserved. Brain-derived neurotrophic factor (BDNF) and its high-affinity full-length (FL)…”
Get full text
Journal Article -
6
Editorial: Meeting of the Portuguese Society for Neurosciences SPN2019
Published in Frontiers in molecular neuroscience (07-10-2021)“…In a brief Research Report, Miranda et al. show that cannabidiol, Δ9-tetrahydrocannabinol, and two synthetic cannabinoids (THJ-018 and EG-018) profoundly…”
Get full text
Journal Article -
7
S327 phosphorylation of the presynaptic protein SEPTIN5 increases in the early stages of neurofibrillary pathology and alters the functionality of SEPTIN5
Published in Neurobiology of disease (01-02-2022)“…Alzheimer's disease (AD) is the most common form of dementia, which is neuropathologically characterized by extracellular senile plaques containing amyloid-β…”
Get full text
Journal Article -
8
Controversies about the cardiovascular effects of OM3FA. Did inappropriate placebos skew clinical trial results?
Published in Pharmacological research (01-02-2021)“…•Several observational studies suggest that omega-3 fatty acids (OM3FA) may reduce cardiovascular risk.•OM3FA and olive oil have antiplatelet and…”
Get full text
Journal Article -
9
From cannabinoids and neurosteroids to statins and the ketogenic diet: new therapeutic avenues in Rett syndrome?
Published in Frontiers in neuroscience (02-07-2019)“…Copyright © 2019 Mouro, Miranda-Lourenço, Sebastião and Diógenes. This is an open-access article distributed under the terms of the Creative Commons…”
Get full text
Journal Article -
10
In vivo bio-distribution and toxicity evaluation of polymeric and lipid-based nanoparticles : a potential approach for chronic diseases treatment
Published in International journal of nanomedicine (01-01-2020)“…© 2020 Fonseca-Gomes et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at…”
Get full text
Journal Article -
11
Microglial Sirtuin 2 shapes long-term potentiation in hippocampal slices
Published in Frontiers in neuroscience (18-06-2020)“…Copyright © 2020 Sa de Almeida, Vargas, Fonseca-Gomes, Tanqueiro, Belo, Miranda-Lourenço, Sebastião, Diógenes and Pais. This is an open-access article…”
Get full text
Journal Article -
12
The neuroprotective action of amidated-kyotorphin on amyloid β peptide-induced Alzheimer’s disease pathophysiology
Published in Frontiers in pharmacology (09-07-2020)“…Copyright © 2020 Belo, Martins, Shvachiy, Costa-Coelho, de Almeida-Borlido, Fonseca-Gomes, Neves, Vicente Miranda, Outeiro, Coelho, Xapelli, Valente, Heras,…”
Get full text
Journal Article -
13
Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson’s disease
Published in Drugs & aging (01-04-2014)“…© Springer International Publishing Switzerland 2014 Parkinson's disease (PD) is a chronic movement disorder typically coupled to progressive degeneration of…”
Get full text
Journal Article -
14
Neuroprotection afforded by adenosine A2A receptor blockade is modulated by corticotrophin-releasing factor (CRF) in glutamate injured cortical neurons
Published in Journal of neurochemistry (01-12-2012)“…© 2012 International Society for Neurochemistry In situations of hypoxia, glutamate excitotoxicity induces neuronal death. The release of extracellular…”
Get full text
Journal Article -
15
Enhanced LTP in aged rats: Detrimental or compensatory?
Published in Neuropharmacology (01-03-2017)“…Age-dependent memory deterioration has been well documented and yet an increase in rat hippocampal LTP upon aging has been reported. This poses the question of…”
Get full text
Journal Article -
16
Neurotrophic factors as a protective strategy in Parkinson's disease
Published in CNS & neurological disorders drug targets (01-12-2010)“…Neurodegenerative disorders are devastating human diseases that include Parkinson's, Huntington's, Alzheimer's, amyotrophic lateral sclerosis, and the frontal…”
Get more information
Journal Article -
17
Brain-derived neurotrophic factor mediates neuroprotection against Aβ-induced toxicity through a mechanism independent on adenosine 2A receptor activation
Published in Growth factors (Chur, Switzerland) (01-01-2015)“…Brain-derived neurotrophic factor (BDNF) promotes neuronal survival through TrkB-FL activation. The activation of adenosine A 2A receptors (A 2A R) is…”
Get full text
Journal Article -
18
Brain-derived neurotrophic factor modulation in response to oxidative stress and corticosterone: role of scopolamine and mirtazapine
Published in Life sciences (1973) (01-12-2024)“…Major Depressive Disorder (MDD) is a very complex disease, challenging to study and manage. The complexities of MDD require extensive research of its…”
Get full text
Journal Article -
19
Selective modulation of epileptic tissue by an adenosine A3 receptor‐activating drug
Published in British journal of pharmacology (01-12-2024)“…Background and Purpose Adenosine, through the A1 receptor (A1R), is an endogenous anticonvulsant. The development of adenosine receptor agonists as antiseizure…”
Get full text
Journal Article -
20
Cholesterol redistribution triggered by CYP46A1 gene therapy improves major hallmarks of Niemann-Pick type C disease but is not sufficient to halt neurodegeneration
Published in Biochimica et biophysica acta. Molecular basis of disease (01-03-2024)“…Cholesterol 24-hydroxylase (CYP46A1) is an exclusively neuronal cytochrome P450 enzyme responsible for converting cholesterol into 24S-hydroxycholesterol,…”
Get full text
Journal Article